Get notified when VIR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Cfo (new) — The CFO is leaving the company to pursue another opportunity.
Vir Biotechnology CFO Jason O'Byrne resigns; CAO Brent Sabatini named interim CFO
Filed July 24, 2026 · Period ending July 20, 2026 · ~1 min read
Key Changes
-
high
CFO Jason O'Byrne resigned effective August 3, 2026, to pursue another opportunity; company states departure not due to disagreement on operations, policies, or practices.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Brent Sabatini, Senior VP and Chief Accounting Officer since February 2023, appointed interim principal financial officer effective August 3; no additional compensation for interim role.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SMMT 10-Q) is open in full — no account needed.
Partner
Trade VIR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 27, 2026 · How we verify